How Hormonal Fluctuations Affect Women’s Brain Health and Mental Disorders

Hormonal changes during a woman's life strongly affect her emotions and thinking, changing the brain's structure, function, and nerve connections, according to presentations at the 39th Congress of the European College of Neuropsychopharmacology in Munich, Germany, Medscape reported.

“The menstrual cycle offers a fantastic opportunity to study neuroplasticity,” emphasized Julia Sacher, MD PhD, professor of cognitive neuroendocrinology at the Medical Faculty of Leipzig University Hospital and the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, Germany, during a plenary session at the 39th Congress of the European College of Neuropsychopharmacology (ECNP) in Munich, Germany.

Historically, hormonal changes were treated as confounding factors in neuroscience research, leading to the frequent exclusion of women from clinical studies. Sacher said that research on women's health is still very limited, with fewer than 0.5% of about 2 million peer-reviewed neuroscience studies published in the last 25 years covering the topic.

Modern PET scans now allow researchers to track hormone-related fluctuations in neurotransmitter systems like serotonin and dopamine, opening pathways to understand neurobiological mechanisms in psychiatric disorders and develop sex-specific treatments.

MAO-A Enzyme Concentrations Increase After Estrogen Levels Fall

Up to 15% of women develop clinically significant postpartum depression within 4 weeks of giving birth, a condition frequently preceded by postpartum blues characterized by crying, irritability, anxiety, and insomnia, Medscape reported. Researchers focused on monoamine oxidase A (MAO-A), an enzyme responsible for neurotransmitter breakdown, using radiolabeled tracers and PET imaging to track enzyme concentrations after childbirth.

Estradiol
Photo: phillytrib.com

Following delivery, estrogen levels fall by a factor of 100 to 1,000. Concurrently, Sacher’s research team observed a greater than 40% increase in MAO-A concentrations across several brain regions within the first 5 days postpartum.

Further investigation revealed elevated MAO-A concentrations in the prefrontal and anterior cingulate cortices, specifically in women experiencing postpartum depression or related symptoms. This regional increase indicates a neurobiological component tied to the sharp estrogen decline, moving beyond purely psychosocial explanations.

Hormone Fluctuations Drive Symptoms in Premenstrual Dysphoric Disorder

Estrogen and progesterone fluctuations during the menstrual cycle also carry distinct clinical implications, particularly in premenstrual dysphoric disorder (PMDD), which affects 3% to 8% of menstruating women, Medscape reported. PMDD is a hormone-dependent mood disorder where symptoms emerge during the luteal phase and subside with menstruation.

How Hormonal Fluctuations Affect Women's Brain Health and Mental Disorders
Photo: Medical News Today

One proposed mechanism is excessive central nervous system sensitivity to normal cyclical hormone changes rather than abnormal hormone levels themselves. During the luteal phase, MAO-A activity and serotonin transporter availability increase, which attenuates serotonergic signaling.

PET scans showed much higher serotonin transporter binding in women with PMDD during the premenstrual phase than in healthy participants, which meant more serotonin was being taken back from the synapse.

Exacerbation of ADHD and Lifelong Estrogen Exposure

Hormonal shifts also influence existing psychiatric conditions like attention-deficit/hyperactivity disorder (ADHD), with many women reporting increased inattention and impulsivity during the premenstrual phase, Medscape reported. PET scans linked these changes to dopaminergic and noradrenergic systems, showing that falling estrogen levels during the late luteal phase decrease dopaminergic activity in the prefrontal cortex.

Expanding the scope of hormonal impact, recent epidemiological data suggest a broader connection between lifetime estrogen exposure and cerebrovascular health. A study of Swedish women found that a longer reproductive span—the period from first menstruation to menopause—was associated with lower levels of cerebral small vessel disease, Medical News Today reported.

Menopausal hormone therapy was similarly linked to a reduced cerebral small vessel disease burden, while experiencing menopause at a later age was tied to a lower chance of developing lacunes, a key marker of small vessel disease, according to Medical News Today.

Study Cohort & Focus Key Hormonal Factor Observed Brain Health Association
Postpartum Depression (Medscape) 100 to 1,000-fold drop in estrogen >40% increase in MAO-A concentration within 5 days postpartum
Premenstrual Dysphoric Disorder (Medscape) Luteal phase hormonal fluctuations Increased serotonin transporter binding and reduced serotonergic signaling
Cerebral Small Vessel Disease (Medical News Today) Longer reproductive span and hormone therapy Lower cerebral small vessel disease burden and fewer lacunes

Clinical Evidence for Cycle-Based Medication Adjustments Remains Limited

While researchers are actively studying how cycle-dependent neurobiological processes can guide individualized care, clinical evidence for cycle-based adjustments to medications like ADHD stimulants remains limited and requires further investigation. For menopausal hormone therapy, researchers emphasize that treatment decisions must remain individualized.

“In particular, there is currently insufficient evidence to recommend menopausal hormone therapy solely for long-term brain protection. Treatment decisions must remain individualized, considering symptoms, age, time since menopause, medical history, and individual risk factors,” Lorenzon and Marseglia said.

Photo of author

Priya Deshmukh - Senior Editor, Health

Priya Deshmukh Senior Editor, Health Deshmukh is a practicing physician and renowned medical journalist, honored for her investigative reporting on public health. She is dedicated to delivering accurate, evidence-based coverage on health, wellness, and medical innovations.

Portugal Face Wales Following Cristiano Ronaldo’s International Retirement